Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Schedule an appointment today
Call to Schedule: 1-866-UH4-CARE
Find Clinical Trials & Studies
Visit the Research & Education Institute

CAR-T Based Immunotherapy for B-Cell Non-Hodgkin Lymphoma

Back to Search Results
Share
Facebook
X
Pinterest
LinkedIn
Email
Print
I'm Interested!
Please call
1-800-641-2422

A Phase 1/1b Multicenter, Open Label Study to Evaluate the Safety of UF-KURE19 Cells in Patients With B Cell Non-Hodgkin Lymphomas

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase I
  • Conditions Being Studied: Cancer - Non-Hodgkin Lymphoma

Study Purpose

This study seeks to determine the safety and efficacy of the infusion of autologous CD19 CAR-T cells that are manufactured using an ultra-fast process.

Who Can Participate

Participants 18 years and older who have been diagnosed with relapsed or refractory non-Hodgkin lymphoma treated may be eligible for this study.

Principal Investigator
Changchun Deng MD
Department/Division
Cancer (Lymphoma)
  • UH IRB: STUDY20220867, 23-315
  • StudyID: CASE2422
  • ClinicalTrials.gov: NCT05400109
I'm Interested!
Please call
1-800-641-2422

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422